|
|
Herpesvirus 6, Human
Research News and Information
Definition of 'Herpesvirus 6, Human'The type species of ROSEOLOVIRUS isolated from patients with AIDS and other LYMPHOPROLIFERATIVE DISORDERS. It infects and replicates in fresh and established lines of hematopoietic cells and cells of neural origin. It also appears to alter NK cell activity. HHV-6; (HBLV) antibodies are elevated in patients with AIDS, Sjogren's syndrome, sarcoidosis, chronic fatigue syndrome, and certain malignancies. HHV-6 is the cause of EXANTHEMA SUBITUM and has been implicated in encephalitis. |
Sunday, November 22, 2009
17 Aug 2009
In general, enveloped viruses are highly dependent on their lipid envelope for entry into host cells. Here, we demonstrated that during the course of virus maturation, a significant proportion of human herpesvirus 6 (HHV-6) envelope proteins were ... Read more...
30 Jul 2009
Drug-induced hypersensitivity syndrome (DIHS)/drug rash with eosinophilia and systemic symptoms (DRESS) is a life-threatening adverse reaction characterized by skin rashes, fever, leukocytosis with eosinophilia or atypical lymphocytosis, lymph node ... Read more...
Pityriasis rosea: an update with a critical appraisal of its possible herpesviral etiology.
30 Jul 2009
Pityriasis rosea is an acute, self-healing exanthem characterized by oval erythematous-squamous lesions of the trunk and limbs, that usually spares face, scalp, palms, and soles. Constitutional symptoms, which have the character of true prodromes; ... Read more...
Latest indexed articles for 'Herpesvirus 6, Human'
These are the very latest articles for this heading:
- Drug reaction with eosinophilia and systemic symptoms: a cause of human herpesvirus 6-related fulminant myocarditis and hepatitis in immunocompetent patients.
14 Sep 2009 - y Human herpesvirus 6 envelope components enriched in lipid rafts: evidence for virion-associated lipid rafts.
17 Aug 2009 - The variable clinical picture of drug-induced hypersensitivity syndrome/drug rash with eosinophilia and systemic symptoms in relation to the eliciting drug.
30 Jul 2009 - Pityriasis rosea: an update with a critical appraisal of its possible herpesviral etiology.
30 Jul 2009 - Microarray-based determination of the lytic cascade of human herpesvirus 6B.
20 Jul 2009 - Challenging complications of treatment--human herpes virus 6 encephalitis and pneumonitis in a patient undergoing autologous stem cell transplantation for relapsed Hodgkin's disease: a case report.
18 Jul 2009 - Evolution of SIV toward RANTES resistance in macaques rapidly progressing to AIDS upon coinfection with HHV-6A.
30 Jun 2009 - Detection and identification of U69 gene mutations encoded by ganciclovir-resistant human herpesvirus 6 using denaturing high-performance liquid chromatography.
23 Jun 2009 - Sensitive, qualitative detection of human herpesvirus-6 and simultaneous differentiation of variants A and B.
19 Jun 2009 - Effect of (r)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine (H2G) and AZT-lipid-PFA on human herpesvirus-6B infected cells.
10 Jun 2009 - HHV-6 Special section. Introduction.
10 Jun 2009 - Prevalence of human herpesvirus-6 chromosomal integration (CIHHV-6) in Italian solid organ and allogeneic stem cell transplant patients.
8 Jun 2009 - Reactivation of human herpesvirus 6 (HHV-6) infection in patients with connective tissue diseases.
7 Jun 2009 - Human herpesvirus-6B induces expression of the human endogenous retrovirus K18-encoded superantigen.
5 Jun 2009 - Detection of human herpesvirus-6 variants in pediatric brain tumors: association of viral antigen in low grade gliomas.
5 Jun 2009 - Different expression of human herpesvirus-6 (HHV-6) load in whole blood may have a significant impact on the diagnosis of active infection.
5 Jun 2009 - HHV-6A infection induces expression of HERV-K18-encoded superantigen.
5 Jun 2009 - Human herpesvirus 6 infections after liver transplantation.
5 Jun 2009 - Association of HHV-6 and HHV-7 reactivation with the development of chronic allograft nephropathy.
Jun 2009 - Nonbacterial purpura fulminans and severe autoimmune acquired protein S deficiency associated with human herpesvirus-6 active replication.
24 May 2009
See a longer list of these articles.
Technical information about 'Herpesvirus 6, Human'
Definition: The type species of ROSEOLOVIRUS isolated from patients with AIDS and other LYMPHOPROLIFERATIVE DISORDERS. It infects and replicates in fresh and established lines of hematopoietic cells and cells of neural origin. It also appears to alter NK cell activity. HHV-6; (HBLV) antibodies are elevated in patients with AIDS, Sjogren's syndrome, sarcoidosis, chronic fatigue syndrome, and certain malignancies. HHV-6 is the cause of EXANTHEMA SUBITUM and has been implicated in encephalitis.
Descriptor UI: D015654
Alternative terms: Herpesvirus 6, Human; Human herpesvirus 6; Human B-Lymphotropic Virus; B-Lymphotropic Virus, Human; B-Lymphotropic Viruses, Human; Human B Lymphotropic Virus; Human B-Lymphotropic Viruses; HBLV; HHV-6; Herpesvirus 6B, Human; Human Herpesvirus 6B; HHV-6B; Herpesvirus 6A, Human; Human Herpesvirus 6A; HHV-6A;
Related Mesh Headings: Exanthema Subitum;
Allowable Qualifiers: classification; drug effects; enzymology; genetics; growth & development; immunology; isolation & purification; metabolism; pathogenicity; physiology; radiation effects; ultrastructure; chemistry;
Tree Number: B04.280.382.150.750.400; B04.909.204.382.150.750.400;
Online Note: use HERPESVIRUS 6, HUMAN to search HERPESVIRUS-6, HUMAN & HUMAN HERPESVIRUS-6 1990-93
History Note: 94; was HERPESVIRUS-6, HUMAN 1990-93; HUMAN HERPESVIRUS-6 was see HERPESVIRUS-6, HUMAN 1990-93
Technical Notes: infection: coord IM with ROSEOLOVIRUS INFECTIONS (IM) but consider also EXANTHEMA SUBITUM